Is STAAR Surgical Stock a Good Investment?
STAAR Surgical Investment Advice | STAA |
- Examine STAAR Surgical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research STAAR Surgical's leadership team and their track record. Good management can help STAAR Surgical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact STAAR Surgical's business and its evolving consumer preferences.
- Compare STAAR Surgical's performance and market position to its competitors. Analyze how STAAR Surgical is positioned in terms of product offerings, innovation, and market share.
- Check if STAAR Surgical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about STAAR Surgical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in STAAR Surgical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if STAAR Surgical is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine STAAR Surgical Stock
Researching STAAR Surgical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are owned by institutional investors. The book value of STAAR Surgical was at this time reported as 8.06. The company has Price/Earnings (P/E) ratio of 460.83. STAAR Surgical recorded a loss per share of 0.41. The entity had not issued any dividends in recent years. The firm had 1:2 split on the 18th of May 1992.
To determine if STAAR Surgical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding STAAR Surgical's research are outlined below:
| STAAR Surgical generated a negative expected return over the last 90 days | |
| STAAR Surgical has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 313.9 M. Net Loss for the year was (20.21 M) with profit before overhead, payroll, taxes, and interest of 239.58 M. | |
| STAAR Surgical has a strong financial position based on the latest SEC filings | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Staar Surgical Co Shares Down 0 percent on Mar 19 |
STAAR Surgical Quarterly Liabilities And Stockholders Equity |
|
STAAR Surgical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in STAAR Surgical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to STAAR Surgical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact STAAR Surgical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises STAAR Surgical's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-10-28 | 2015-09-30 | -0.04 | -0.0441 | -0.0041 | 10 | ||
2015-02-25 | 2014-12-31 | -0.02 | -0.03 | -0.01 | 50 | ||
2013-10-30 | 2013-09-30 | 0.02 | 0.01 | -0.01 | 50 | ||
2015-07-29 | 2015-06-30 | -0.03 | -0.0409 | -0.0109 | 36 | ||
2024-10-30 | 2024-09-30 | 0.18 | 0.2 | 0.02 | 11 | ||
2023-05-03 | 2023-03-31 | 0.07 | 0.05 | -0.02 | 28 | ||
2017-08-02 | 2017-06-30 | -0.03 | -0.01 | 0.02 | 66 | ||
2017-05-03 | 2017-03-31 | -0.06 | -0.04 | 0.02 | 33 |
STAAR Surgical Target Price Consensus
STAAR target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. STAAR Surgical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 14 | Buy |
Most STAAR analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand STAAR stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of STAAR Surgical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSTAAR Surgical Target Price Projection
STAAR Surgical's current and average target prices are 17.72 and 40.98, respectively. The current price of STAAR Surgical is the price at which STAAR Surgical is currently trading. On the other hand, STAAR Surgical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
STAAR Surgical Market Quote on 22nd of March 2025
Target Price
Analyst Consensus On STAAR Surgical Target Price
STAAR Surgical Analyst Ratings
STAAR Surgical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about STAAR Surgical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of STAAR Surgical's financials, market performance, and future outlook by experienced professionals. STAAR Surgical's historical ratings below, therefore, can serve as a valuable tool for investors.Know STAAR Surgical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as STAAR Surgical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading STAAR Surgical backward and forwards among themselves. STAAR Surgical's institutional investor refers to the entity that pools money to purchase STAAR Surgical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Yunqi Capital Ltd | 2024-12-31 | 767.4 K | Millennium Management Llc | 2024-12-31 | 759.1 K | Defender Capital, Llc. | 2024-12-31 | 701.6 K | Geneva Capital Management | 2024-12-31 | 662.8 K | Northern Trust Corp | 2024-12-31 | 521.9 K | Palo Alto Investors, Llc | 2024-12-31 | 500.8 K | Charles Schwab Investment Management Inc | 2024-12-31 | 444.3 K | Bank Of America Corp | 2024-12-31 | 439.5 K | Artisan Partners Limited Partnership | 2024-12-31 | 439 K | Broadwood Capital Inc | 2024-12-31 | 10.8 M | Blackrock Inc | 2024-12-31 | 8.2 M |
STAAR Surgical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 883.91 M.Market Cap |
|
STAAR Surgical's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.08 | |
| Return On Capital Employed | 0.11 | 0.12 | |
| Return On Assets | 0.08 | 0.08 | |
| Return On Equity | 0.11 | 0.11 |
Determining STAAR Surgical's profitability involves analyzing its financial statements and using various financial metrics to determine if STAAR Surgical is a good buy. For example, gross profit margin measures STAAR Surgical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of STAAR Surgical's profitability and make more informed investment decisions.
STAAR Surgical's Earnings Breakdown by Geography
Please note, the presentation of STAAR Surgical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, STAAR Surgical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of STAAR Surgical's management manipulating its earnings.
Evaluate STAAR Surgical's management efficiency
STAAR Surgical has return on total asset (ROA) of (0.0155) % which means that it has lost $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0516) %, meaning that it created substantial loss on money invested by shareholders. STAAR Surgical's management efficiency ratios could be used to measure how well STAAR Surgical manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.08. The current year's Return On Capital Employed is expected to grow to 0.12. At present, STAAR Surgical's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 148.7 M, whereas Intangible Assets are forecasted to decline to about 147.9 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.48 | 5.75 | |
| Tangible Book Value Per Share | 5.43 | 5.71 | |
| Enterprise Value Over EBITDA | 112.02 | 117.62 | |
| Price Book Value Ratio | 16.67 | 26.04 | |
| Enterprise Value Multiple | 112.02 | 117.62 | |
| Price Fair Value | 16.67 | 26.04 | |
| Enterprise Value | 109.5 M | 104.1 M |
Evaluating the management effectiveness of STAAR Surgical allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The STAAR Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta 0.664 |
Basic technical analysis of STAAR Stock
As of the 22nd of March, STAAR Surgical owns the risk adjusted performance of (0.07), and Standard Deviation of 4.55. In relation to fundamental indicators, the technical analysis model makes it possible for you to check practical technical drivers of STAAR Surgical, as well as the relationship between them.STAAR Surgical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific STAAR Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on STAAR Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases STAAR Surgical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
STAAR Surgical's Outstanding Corporate Bonds
STAAR Surgical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. STAAR Surgical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most STAAR bonds can be classified according to their maturity, which is the date when STAAR Surgical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US85236FAA12 Corp BondUS85236FAA12 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Understand STAAR Surgical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing STAAR Surgical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (1.93) | |||
| Mean Deviation | 3.09 | |||
| Coefficient Of Variation | (1,092) | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.66 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | (1.94) | |||
| Maximum Drawdown | 30.99 | |||
| Value At Risk | (5.18) | |||
| Potential Upside | 6.86 | |||
| Skewness | (2.09) | |||
| Kurtosis | 11.56 |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | (1.93) | |||
| Mean Deviation | 3.09 | |||
| Coefficient Of Variation | (1,092) | |||
| Standard Deviation | 4.55 | |||
| Variance | 20.66 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.06) | |||
| Treynor Ratio | (1.94) | |||
| Maximum Drawdown | 30.99 | |||
| Value At Risk | (5.18) | |||
| Potential Upside | 6.86 | |||
| Skewness | (2.09) | |||
| Kurtosis | 11.56 |
Consider STAAR Surgical's intraday indicators
STAAR Surgical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of STAAR Surgical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 54997.75 | |||
| Daily Balance Of Power | (0.33) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 17.91 | |||
| Day Typical Price | 17.84 | |||
| Price Action Indicator | (0.29) | |||
| Period Momentum Indicator | (0.20) | |||
| Relative Strength Index | 42.72 |
STAAR Surgical Corporate Filings
F4 | 20th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 3rd of March 2025 Other Reports | ViewVerify | |
10K | 21st of February 2025 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
STAAR Stock media impact
Far too much social signal, news, headlines, and media speculation about STAAR Surgical that are available to investors today. That information is available publicly through STAAR media outlets and privately through word of mouth or via STAAR internal channels. However, regardless of the origin, that massive amount of STAAR data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of STAAR Surgical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of STAAR Surgical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to STAAR Surgical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive STAAR Surgical alpha.
STAAR Surgical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards STAAR Surgical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
STAAR Surgical Historical Investor Sentiment
Investor biases related to STAAR Surgical's public news can be used to forecast risks associated with an investment in STAAR. The trend in average sentiment can be used to explain how an investor holding STAAR can time the market purely based on public headlines and social activities around STAAR Surgical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
STAAR Surgical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for STAAR Surgical and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average STAAR Surgical news discussions. The higher the estimate score, the more favorable the investor's outlook on STAAR Surgical.
STAAR Surgical Maximum Pain Price Across June 20th 2025 Option Contracts
STAAR Surgical's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of STAAR Surgical close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of STAAR Surgical's options.
When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STAAR Surgical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.018 | Earnings Share (0.41) | Revenue Per Share | Quarterly Revenue Growth (0.36) | Return On Assets |
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between STAAR Surgical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.